mhurhangee/patent-ind-claim-en huggingface dataset:
A surgical access device comprising: an inner tube including one or more engagement features of a first type disposed on an outer surface thereof and wherein the inner tube comprises one or more slots formed along part of the length of the inner tube, through the external and internal surfaces of the inner tube ; and an outer tube telescopically mated with the inner tube , and including one or more engagement features of a second type formed at least on the inner surface thereof, wherein the outer tube comprises one or more slots formed along part of the length of the outer tube, through the external and internal surface of the outer tube ; wherein the first type of engagement features and the second type of engagement features are complementary to each other, and an auxiliary tool comprising at least one tab configured to engage with the at least one slot formed in the outer tube and the at least one slot formed in the inner tube to facilitate extension or retraction of the outer tube relative to the inner tube ; wherein a length of the surgical access device is adjusted by applying opposite proximal or distal forces on the inner tube and outer tube , thereby causing engagement features of the inner tube to slip from the corresponding one or more engagement features of the outer tube to adjacent others of the one or more engagement feature of the outer tube. an inner tube including one or more engagement features of a first type disposed on an outer surface thereof and wherein the inner tube comprises one or more slots formed along part of the length of the inner tube, through the external and internal surfaces of the inner tube ; and an outer tube telescopically mated with the inner tube , and including one or more engagement features of a second type formed at least on the inner surface thereof, wherein the outer tube comprises one or more slots formed along part of the length of the outer tube, through the external and internal surface of the outer tube ; wherein the first type of engagement features and the second type of engagement features are complementary to each other, and an auxiliary tool comprising at least one tab configured to engage with the at least one slot formed in the outer tube and the at least one slot formed in the inner tube to facilitate extension or retraction of the outer tube relative to the inner tube ; wherein a length of the surgical access device is adjusted by applying opposite proximal or distal forces on the inner tube and outer tube , thereby causing engagement features of the inner tube to slip from the corresponding one or more engagement features of the outer tube to adjacent others of the one or more engagement feature of the outer tube.
A glass forming individual section machine , comprising: a machine frame having a glass gob loading axis (Z'); a traversable blank side , including a blank mold configured to form a glass gob into a parison and having a blank mold vertical axis ( V 1 ); and a mold carriage movably carried on the machine frame and coupled to the traversable blank side to linearly translate the traversable blank side toward the glass gob loading axis to align the blank mold vertical axis with the glass gob loading axis and to linearly translate the traversable blank side away from the glass gob loading axis. a machine frame having a glass gob loading axis (Z'); a traversable blank side , including a blank mold configured to form a glass gob into a parison and having a blank mold vertical axis ( V 1 ); and a mold carriage movably carried on the machine frame and coupled to the traversable blank side to linearly translate the traversable blank side toward the glass gob loading axis to align the blank mold vertical axis with the glass gob loading axis and to linearly translate the traversable blank side away from the glass gob loading axis.
A nanoparticle comprising (i) a lipid component comprising a compound having the structure , and (ii) a modified RNA comprising any one of SEQ ID NOs: 1 and 3-5, encoding a VEGF-A polypeptide of SEQ ID NO: 2. (i) a lipid component comprising a compound having the structure , and (ii) a modified RNA comprising any one of SEQ ID NOs: 1 and 3-5, encoding a VEGF-A polypeptide of SEQ ID NO: 2.
A defibrillator which is configured to operate while communicating with a Cardio Pulmonary Resuscitation (CPR) assisting device , wherein said Cardio Pulmonary Resuscitation assisting device comprises a sound outputting unit , and is configured to stop a guidance sound output from said sound outputting unit after a communication connection with the defibrillator is established, the defibrillator comprising: a communicating unit which is configured to establish a communication connection with the Cardio Pulmonary Resuscitation assisting device to communicate with the Cardio Pulmonary Resuscitation assisting device; a controlling unit which is configured to control the defibrillator; and a sound outputting unit which is configured to perform a sound output in accordance with a control of the controlling unit and, when, after the communicating unit establishes the communication connection with the Cardio Pulmonary Resuscitation assisting device and a guidance sound output of the Cardio Pulmonary Resuscitation assisting device is stopped, the controlling unit controls the sound outputting unit of the defibrillator to output guidance sounds. a communicating unit which is configured to establish a communication connection with the Cardio Pulmonary Resuscitation assisting device to communicate with the Cardio Pulmonary Resuscitation assisting device; a controlling unit which is configured to control the defibrillator; and a sound outputting unit which is configured to perform a sound output in accordance with a control of the controlling unit and, when, after the communicating unit establishes the communication connection with the Cardio Pulmonary Resuscitation assisting device and a guidance sound output of the Cardio Pulmonary Resuscitation assisting device is stopped, the controlling unit controls the sound outputting unit of the defibrillator to output guidance sounds.
A polybutylene terephthalate (PBT) elastomer composition having excellent heat resistance, the composition comprising: 100 parts by weight of a PBT resin; 10 to 120 parts by weight of Di(2-propylheptyl)phthalate, which is an ester-based environmentally friendly plasticizer; and 10 to 120 parts by weight of a thermoplastic copolyester elastomer (TPEE) resin; and 10 to 100 parts by weight of a core-shell type copolymer, wherein the core-shell type copolymer comprises any one selected from among an acrylic rubber-based core-shell copolymer, a butadiene rubber-based core-shell type copolymer, and a silicone/acrylic rubber-based core-shell copolymer. 100 parts by weight of a PBT resin; 10 to 120 parts by weight of Di(2-propylheptyl)phthalate, which is an ester-based environmentally friendly plasticizer; and 10 to 120 parts by weight of a thermoplastic copolyester elastomer (TPEE) resin; and 10 to 100 parts by weight of a core-shell type copolymer, wherein the core-shell type copolymer comprises any one selected from among an acrylic rubber-based core-shell copolymer, a butadiene rubber-based core-shell type copolymer, and a silicone/acrylic rubber-based core-shell copolymer.
A compound of the formula I wherein R 1 is hydrogen, methyl, ethyl, n-propyl, isobutyl, cyclopropylmethyl or HC≡CCH 2 -; A 1 is N or C-R 2c ; R 2c is H, halogen, C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, or C 1 -C 3 haloalkoxy; R 2a is C 3 -C 6 cycloalkyl, C 3 -C 6 cycloalkoxy, C 3 -C 6 cycloalkyl substituted with one to three substituents independently selected from C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, cyano, and halogen, C 3 -C 6 cycloalkoxy substituted with one to three substituents independently selected from C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, cyano, and halogen, C 3 -C 6 cycloalkylC 1 -C 4 alkyl, C 3 -C 6 cycloalkylC 1 -C 4 alkoxy, C 3 -C 6 cycloalkylC 1 -C 4 alkyl substituted with one to five substituents independently selected from C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, cyano, and halogen, C 3 -C 6 cycloalkylC 1 -C 4 alkoxy substituted with one to five substituents independently selected from C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, cyano, and halogen, C 1 -C 5 cyanoalkyl, C 1 -C 4 alkylsulfonyl, C 1 -C 4 haloalkylsulfonyl, C 1 -C 4 alkylsulfinyl, or C 1 -C 4 haloalkylsulfinyl; R 2b is H, halogen, C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 haloalkylthio, C 1 -C 3 alkoxy, C 1 -C 3 haloalkoxy, SF 5 , or CN; R 3 is methyl; A 2 is CR 4b or N; R 4b is hydrogen, or halogen; R 4a is cyano, or C 1 -C 3 haloalkoxy; R 5a and R 5b , independent of each other, are selected from hydrogen, halogen, and methyl; or agrochemically acceptable salts, stereoisomers, enantiomers, tautomers and N-oxides of the compounds of formula I. R 1 is hydrogen, methyl, ethyl, n-propyl, isobutyl, cyclopropylmethyl or HC≡CCH 2 -; A 1 is N or C-R 2c ; R 2c is H, halogen, C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, or C 1 -C 3 haloalkoxy; R 2a is C 3 -C 6 cycloalkyl, C 3 -C 6 cycloalkoxy, C 3 -C 6 cycloalkyl substituted with one to three substituents independently selected from C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, cyano, and halogen, C 3 -C 6 cycloalkoxy substituted with one to three substituents independently selected from C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, cyano, and halogen, C 3 -C 6 cycloalkylC 1 -C 4 alkyl, C 3 -C 6 cycloalkylC 1 -C 4 alkoxy, C 3 -C 6 cycloalkylC 1 -C 4 alkyl substituted with one to five substituents independently selected from C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 alkoxy, cyano, and halogen, C 3 -C 6 cycloalkylC 1 -C 4 alkoxy substituted with one to five substituents independently selected from C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, cyano, and halogen, C 1 -C 5 cyanoalkyl, C 1 -C 4 alkylsulfonyl, C 1 -C 4 haloalkylsulfonyl, C 1 -C 4 alkylsulfinyl, or C 1 -C 4 haloalkylsulfinyl; R 2b is H, halogen, C 1 -C 3 alkyl, C 1 -C 3 haloalkyl, C 1 -C 3 haloalkylthio, C 1 -C 3 alkoxy, C 1 -C 3 haloalkoxy, SF 5 , or CN; R 3 is methyl; A 2 is CR 4b or N; R 4b is hydrogen, or halogen; R 4a is cyano, or C 1 -C 3 haloalkoxy; R 5a and R 5b , independent of each other, are selected from hydrogen, halogen, and methyl; or agrochemically acceptable salts, stereoisomers, enantiomers, tautomers and N-oxides of the compounds of formula I.
A computer-implemented method for determination of noise in a sampled cardiac electrical signal, said sampled cardiac electrical signal comprising a consecutive sequence of samples, each sample having an amplitude, the amplitudes in general being positive or negative, the method comprising the steps of - providing a signal quality check window that comprises a number of consecutive samples - providing at least one upper threshold for a signal amplitude - providing at least one lower threshold for a signal amplitude said at least one upper threshold and said at least one lower threshold defining at least three amplitude ranges, a high range for signal amplitude exceeding said upper threshold, a medium range for amplitudes between said upper threshold and said lower threshold and a low range for amplitude below said lower threshold - comparing each sample within said quality check window with said upper threshold and with said lower threshold; and - performing a signal quality analysis for said signal sample by: a) analyzing the changes in amplitude of successive samples within said quality check window, said change in amplitude being determined for any two adjacent sample pairs within said quality check window by comparing to which amplitude ranges the amplitudes of the signal samples of the respective sample pair belong to, and by b) determining a threshold crossing number reflecting the number of thresholds between each two adjacent signal samples of each sample pair. - providing a signal quality check window that comprises a number of consecutive samples - providing at least one upper threshold for a signal amplitude - providing at least one lower threshold for a signal amplitude said at least one upper threshold and said at least one lower threshold defining at least three amplitude ranges, a high range for signal amplitude exceeding said upper threshold, a medium range for amplitudes between said upper threshold and said lower threshold and a low range for amplitude below said lower threshold - comparing each sample within said quality check window with said upper threshold and with said lower threshold; and - performing a signal quality analysis for said signal sample by: a) analyzing the changes in amplitude of successive samples within said quality check window, said change in amplitude being determined for any two adjacent sample pairs within said quality check window by comparing to which amplitude ranges the amplitudes of the signal samples of the respective sample pair belong to, and by b) determining a threshold crossing number reflecting the number of thresholds between each two adjacent signal samples of each sample pair.
A communication system for receiving incoming data streams of samples from one or more channels , the communication system comprising: - a plurality of input buffers adapted for buffering the incoming data streams, - a receiver adapted for sequentially processing data from the different input buffers wherein a processing rate of the receiver is higher than or equal to an incoming data rate of the incoming data, wherein the receiver is adapted for processing the incoming data in a frame detection phase in which a start point of frames and/or subframes in the incoming data is detected, and in a frame demodulation phase in which the frames and/or subframes are demodulated into bits, - an that the communication system comprises context memory adapted for saving an internal status of the receiver after processing the data corresponding with an input buffer before switching to a next input buffer and for restoring the internal status of the receiver with a saved internal status related to the next input buffer before switching to the next input buffer characterized in that the internal status of the receiver related to an input buffer is only saved and restored in the frame detection phase , or before and after demodulating subframes. - a plurality of input buffers adapted for buffering the incoming data streams, - a receiver adapted for sequentially processing data from the different input buffers wherein a processing rate of the receiver is higher than or equal to an incoming data rate of the incoming data, wherein the receiver is adapted for processing the incoming data in a frame detection phase in which a start point of frames and/or subframes in the incoming data is detected, and in a frame demodulation phase in which the frames and/or subframes are demodulated into bits, - an that the communication system comprises context memory adapted for saving an internal status of the receiver after processing the data corresponding with an input buffer before switching to a next input buffer and for restoring the internal status of the receiver with a saved internal status related to the next input buffer before switching to the next input buffer characterized in that the internal status of the receiver related to an input buffer is only saved and restored in the frame detection phase , or before and after demodulating subframes.
An implant for improving coaptation of an atrioventricular valve in a heart , the atrioventricular valve having a native first leaflet, a native second leaflet and optionally an annulus adjacent a wall of an atrium of the heart , the implant comprising a support structure configured to be arranged on and fixed to the annulus or to at least one of the first and second native leaflets, wherein the support structure comprises an upper support element to be arranged on a superior surface of the annulus or of the at least one of the first and second native leaflets and a lower support element to be arranged on an inferior surface of the annulus or of the at least one of the first and second native leaflets, the upper and the lower support elements each comprising connection means cooperating which each other for interconnecting the upper and the lower support element while clamping a section of the annulus or of the at least one of the first and second native leaflets between the upper support element and the lower support element , the implant further comprising retention means fixed to the support structure so as to prevent prolapse of the at least one native leaflet, characterized in that the support structure comprises a resting element that is configured to rest against the wall of the atrium adjacent the valve , wherein the lower support element carries a holding element for holding the retention means .
Composition containing, in a cosmetically acceptable medium, at least: a) at least one aqueous phase and b) composite particles A in spherical form, having a mean size of between 0.1 and 30 μm comprising at least one particulate UV-screening agent and a core constituted of at least one inorganic material and/or of at least one organic material, and c) free particles B of inorganic UV-screening agent having a mean elementary size greater than 0.07 μm, the content of composite particles A in the composition according to the invention ranges from 1% to 70% relative to the total weight of the cosmetic composition. the content of particles B in the composition according to the invention ranges from 0.1% and 40% relative to the total weight of the composition, the core of the spherical composite particles A contains a material or a mixture of materials chosen from: - SiO 2 , - poly(methyl methacrylate), - copolymers of styrene and of a C1/C5 alkyl (meth)acrylate derivative, the particulate UV-screening agent is inorganic and chosen from titanium oxides, the particles B of inorganic UV-screening agent are metal oxides treated with at least one surface-treatment agent, in hydrophobically-modified coated form, chosen from : - a dimethicone-treated titanium dioxide; - a titanium dioxide treated with a silica/alumina/stearic acid or alumina/stearic acid mixture; - an oily dispersion of TiO 2 particles treated with a mixture of stearic acid, polyhydroxystearic acid and alumina. a) at least one aqueous phase and b) composite particles A in spherical form, having a mean size of between 0.1 and 30 μm comprising at least one particulate UV-screening agent and a core constituted of at least one inorganic material and/or of at least one organic material, and c) free particles B of inorganic UV-screening agent having a mean elementary size greater than 0.07 μm, - SiO 2 , - poly(methyl methacrylate), - copolymers of styrene and of a C1/C5 alkyl (meth)acrylate derivative, - a dimethicone-treated titanium dioxide; - a titanium dioxide treated with a silica/alumina/stearic acid or alumina/stearic acid mixture; - an oily dispersion of TiO 2 particles treated with a mixture of stearic acid, polyhydroxystearic acid and alumina.
A snowboard for ski-touring, intended to receive a shoe binding (F) comprising an upper face, a lower face and lateral edges, at least one of which is provided with a series of notches , characterized in that each edge of said notches defines, on the one hand, a transverse stop face extending on the rear side of the edge and enabling the board to be stopped in the backward direction and, on the other hand, a longitudinal face for connecting the notches together which extends on the front side of the edge , relative to the front of the board between said notches and which enables the sliding forward.
A method for high throughput glycan analysis, comprising: loading a plurality of glycoprotein samples in a plurality of loading wells; denaturing the glycoprotein samples in the loading wells using a denaturing solution; cleaving a glycan from each of the denatured glycoprotein samples in the loading wells using a glycan cleaving enzyme; labeling the cleaved glycans with a charged fluorescent label; applying an electric field configured to migrate the labeled glycans from the loading wells across an ion permeable membrane and into and along one of a plurality of capillaries arranged in correspondence with the loading wells, each of the capillaries including a first portion including a stacking gel, including between 4% to 8% acrylamide, and a second portion including a resolving gel, including between 25% and 35% acrylamide; exciting the labeled glycans migrating along the capillaries with a light source adapted to cause the labeled glycans to emit fluorescent radiation; detecting fluorescent radiation emitted by the labeled glycans; and analyzing the labeled glycans based on the detected fluorescent radiation. loading a plurality of glycoprotein samples in a plurality of loading wells; denaturing the glycoprotein samples in the loading wells using a denaturing solution; cleaving a glycan from each of the denatured glycoprotein samples in the loading wells using a glycan cleaving enzyme; labeling the cleaved glycans with a charged fluorescent label; applying an electric field configured to migrate the labeled glycans from the loading wells across an ion permeable membrane and into and along one of a plurality of capillaries arranged in correspondence with the loading wells, each of the capillaries including a first portion including a stacking gel, including between 4% to 8% acrylamide, and a second portion including a resolving gel, including between 25% and 35% acrylamide; exciting the labeled glycans migrating along the capillaries with a light source adapted to cause the labeled glycans to emit fluorescent radiation; detecting fluorescent radiation emitted by the labeled glycans; and analyzing the labeled glycans based on the detected fluorescent radiation.